PODD•benzinga•
Insulet's RADIANT Trial Shows Omnipod 5 Improves Glycemic Control by 0.8% Over Three Months; Achieves +5.4 Hours in Target Glucose Range Daily; Primary Endpoint Met
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 19, 2025 by benzinga